Arcturus Therapeutics Holdings (ARCT) Total Debt (2018 - 2025)

Arcturus Therapeutics Holdings has reported Total Debt for 7 years, with the latest figure at $15.0 million in Q1 2025.

• For the quarter ending Q1 2025, Total Debt changed N/A year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2025 stood at $15.0 million (changed N/A YoY), and the FY2022 full-year result was $60.7 million, down 3.89% from the prior year.
• Total Debt for Q1 2025 stood at $15.0 million, down from $20.0 million in the prior quarter.
• The five-year high for Total Debt was $63.5 million in Q1 2022, with the low at $15.0 million in Q1 2025.
• Historically, Total Debt has averaged $52.8 million across 4 years, with a median of $61.0 million in 2021.
• Annual changes were most pronounced in 2021 — Total Debt soared 318.07% — and 2023, when it sank 66.52%.
• Arcturus Therapeutics Holdings' Total Debt stood at $63.1 million in 2021, then decreased by 3.89% to $60.7 million in 2022, then sank by 67.03% to $20.0 million in 2023, then retreated by 25.0% to $15.0 million in 2025.
• The last three Total Debt figures came in at $15.0 million (Q1 2025), $20.0 million (Q3 2023), and $60.7 million (Q4 2022), per Business Quant data.